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ABSTRACT
THE EFFECTS OF PRE-MAXIMAL EXERTION INHALATION OF AMMONIA
AND THE PERFORMANCE EFFECTS DURING DEADLIFT MAXIMAL TESTS

Justin Nicholas Vigil
Old Dominion University, 2015
Director: Dr. David Branch
The purpose of this study was to investigate the effects of ammonia as a stimulant
on athletic performance during a deadlift one maximal repetition (1-RM) absolute
strength test. It was hypothesized that ammonia inhalation would result in a larger 1-RM,
possibly due to immediate catecholamine release attributed to the fight-or-flight response.
If proven effective, ammonia inhalation would present an option to increase power and
strength performance during training and competition based on an acute manipulation of
natural occurring hormones, eliminating the side effects attributed to other
supplementation methods. Subjects (n = 10 males, X±SD age = 21±1 years, mass =
72.5±6.8 kg; n = 10 female, age = 22±5 years, mass = 66.2±8.1 kg) were required to have
at least two years of resistance training experience while lacking a history of asthma,
lightheadedness, fainting, anaphylaxis, sickle cell traits, and other respiratory disorders.
After a baseline 1-RM test, subjects were paired by 1-RM performance and gender, then
randomly assigned in a counterbalanced treatment order to control/blinding water or
ammonia trials after a minimum 72-hour recovery period for another 1-RM test involving
attempts at 100%, 102.5%, 105%, and 107.5% of the established 1-RM value. Testing
was then repeated after the minimum rest period for the remaining trial. Results revealed
the expected sex main effect for dead lift 1-RM (93.0±29.5 [females]; 152.0±29.5 kg
[males] (1,18F = 20.09, p<0.001), but no trial main effect (2,36F = 0.135, p = 0.874) or sex
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by trial interaction effect (baseline = 93.0±15.3; 151.8±42.3 kg; water = 92.0±12.5;
150.9±37.8 kg; ammonia = 92.5±16.4; 153.4±37.9 kg) for females and males,
respectively (2,36F = 0.591, p = 0.559). Limitations to this study included the possibility
that the delivery system was flawed; usage of an ammonia concentration not potent
enough; and other extraneous factors. Within the limitations of this study, there is no
basis for the support of ammonia inhalation to improve 1-RM efforts in training,
competition, or any other circumstance.
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CHAPTER I – INTRODUCTION

Over the course of history, changes in scoring, participation, regulations,
equipment, and athleticism requirements have been introduced to all sports. With some of
these changes, the lines of legal and illegal performance have become blurred (Kisaalita
& Robinson 2014). In addition to the introduction of technologically superior equipment
and materials, supplements such as steroids have become the center of sports
enhancement, with coaches and athletes often years or decades ahead of regulatory
agencies. Many of these substances are currently in use to artificially increase the levels
of testosterone, human growth hormone, and other performance-enhancing hormones for
the purpose of improving both chronic and acute performance.
Anabolic supplements can be utilized by strength and power athletes over a
long-term period to increase overall strength, power, muscle mass, and fat loss. Other
methods are favored for their ability to mimic natural physiological processes such as
adapting to a hypoxic environment while training at higher altitudes (which is allowed by
the World Anti-Doping Agency [WADA]) without the need to actually train at altitude.
While some substances are utilized for their acute effects and others for more chronic
adaptations, some of these known supplements have been banned by most, if not all,
drug-monitoring athletic agencies (Ramachandra et al., 2012). Positive results are based
on the detection of prohibited substances, their metabolites, and markers in biological
samples supplied by athletes; usually at a randomized and unknown time and place. As
stated by the WADA, substances classified as “exogenous” refer to those that cannot
naturally be produced by the body while “endogenous” substances are ordinarily
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produced by the body. What links these substances together is that they all not only target
a specific hormone, but they often are designed to mimic its effects or prevent any sideeffects of its greater presence, while increasing the substance’s levels in the body to
abnormally high concentrations. Increased concentrations of banned substances and/or
any metabolites are criteria for a positive test and possible suspension and/or
disqualification of the athlete. The WADA classifies these substances as banned from
competition through the following criteria: 1) enhances performance, 2) represents a risk
to health, and 3) violates the “spirit of sport” (Savelescu et al., 2004). Within these
criteria, it is possible for athletes to utilize steroids for medical purposes where that intake
is prescribed as a component of a treatment for health, rehabilitative, or preventative
measures.
However, these benefits to performance come at a cost, as many of these
supplements have negative long-term consequences ranging from mental health
(Lindqvist et al., 2013), structural, circulatory changes and responses (Boyadjiev et al.,
2010), organ complications, to even death (Montisci et al., 2012). Hence, the purpose of
this study is to find an alternate method of enhancing acute strength performance while
eliminating any negative chronic consequences. It has been suggested (Gorguner &
Akgun, 2010) that there are few, if any, chronic consequences of acute inhalation injury
from certain gaseous substances, in this case ammonia, when the proper precautions are
taken. However, there is very little well designed research on the efficacy of ammonia
inhalation on strength performance.
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STATEMENT OF PROBLEM
In today’s performance focused athletics, finding methods to increase
performance, both in training and competition while not violating any regulations, has
become a vital component in strength and conditioning programs at all levels of athletics
from professional to high school competitions.
For the purpose of this study, the methodology was designed to observe the
possibility of enhancing 1 repetition for maximal load lifts (1-RM) without the chronic
consequences commonly associated with established methods of performance
enhancement, specifically steroids and other such substances. The largest consideration is
whether it is possible to influence the body’s natural endocrine systems and processes
without any chronic side effects or consequences while staying within the current
regulations in place by the WADA. Specifically, the goal of the current study was to
examine the acute effect of inhaling small amounts of ammonia prior to performance of a
strength exercise; in this case the deadlift exercise and the loads achieved in a standard 1RM test.
There are several methodological challenges with identifying any potential
ergogenic effect caused by this inhalation. It is difficult to measure catecholamines
(epinephrine, norepinephrine) and other stress hormones; hence the lack of measurement
in this study and the assumption that acute sympathetic arousal is the mechanism for any
observed ergogenic effect of ammonia inhalation. This is based on the assumption that
the hypothalamic-pituitary-adrenal axis (HPA axis) is the origin of the mechanism
causing the release of the catecholamines (epinephrine, norepinephrine, cortisol, ACTH,
etc.) following ammonia inhalant during the 1-RM tests. Previous research has
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demonstrated that the HPA axis stimulates the release of cortisol from the adrenal gland
as a reaction to stress (Embi & Scherlag, 2014). It has also been observed that there is no
negative effect on HPA-axis stimulation in children after inhaling glucocorticosteroids
(Wolthers & Honour, 1998). However, due to the speed of both the response to inhalation
and the brief time frame of effect, it is assumed that sympathetic nervous system
stimulation and the corresponding norepinephrine release is the focus of this study.
Even though ammonia is an essential DNA, RNA, and protein synthesis
metabolite for the maintenance of the acid-base balance (Gerberding, 2004), exposure to
concentrated gases result in upper respiratory airway burns and obstructions, distress, and
edema. However, acute exposure to 500 ppm levels or higher has also been shown to
increase respiratory minute volume, which is well below the concentrations needed to the
previously mentioned complications.
NULL HYPOTHESIS (H0:)
There will be no significant effect of the ammonia inhalant independent variable
on 1-RM test results when compared to the control inhalant or the baseline 1-RM tests.
RESEARCH HYPOTHESIS (HA:)
The ammonia inhalant treatment will significantly increase 1-RM compared to the
control inhalant and baseline treatments.
ASSUMPTIONS
For the purpose of this study, it was assumed that all subjects, due to their
resistance training experience, were performing the deadlift with proper form. It was also
assumed that the subjects were familiar with 1-RM conditions, and were willing to exert
themselves to a true 1-RM and did not end a session without lifting at their maximum
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effort. It was also assumed that all subjects did not change their daily routine during the
duration of the testing trials, remained consistent with no changes to their personal
training program, and had access to the same facilities and equipment over the past six
months; thus minimizing bias based on environment and availability of resources for
training. Finally, it was also assumed that subjects’ diets did not change, and there was no
consumption of alternate or additional ergogenic or dietary supplements during the
course of this study while still meeting the necessary caloric and nutritional consumption
needed for their metabolic demands.
DELIMITATIONS
In this study, the back squat and bench press are not being included despite their
status as commonly tested multi-joint exercises due to the limited or non-existent data on
the deadlift exercise. This was based on filling the current lack on scientific knowledge,
while also allowing minimal training to be required to effectively perform the simple
technique of the deadlift. This study was also focusing on subjects from the ages of 18 to
24 years due to the high relevancy of the topic in question to athletes of similar ages.
This is the same age group where many athletes are on the brink of professional careers,
and often where they are looking for any methods, banned or otherwise, that allows them
to distinguish themselves within the vast numbers of rival athletes.
LIMITATIONS
All testing took place at the Student Recreation Center at Old Dominion
University, which may have limited data collection due to the lack of ideal testing
locations. The only current deadlifting platform was located in the middle of the facility
and was often surrounded by students pursuing their various fitness goals, providing a
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substantial quantity and range of verbal, visual, and physical distractions during testing.
These stressors may have helped to replicate the environment found in many powerlifting competition and athletic training settings.

Any lack of judgment on the

researcher’s part pertaining to subjects reaching full hip, knee, and elbow extension for
full control of the loads during these lifts could have resulted in false achieved lifts. Due
to the fact that subjects were full time students, scheduling three trials around academic
courses became a threat to the study. Steps were taken to standardize the testing time of
day despite the length of time between trials to account for diurnal variation and other
metabolic considerations to assure consistent experimental conditions.
SIGNIFICANCE OF THE PROBLEM
This study could provide evidence for the ergogenic effect of ammonia inhalant,
a legal external substance, in increasing acute muscular strength as measured by a
deadlift 1-RM. This would allow athletes to improve their performance during training
and competition without using banned agents such as androgenic-anabolic steroids that
have been banned by the WADA and have harmful effects on health.
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CHAPTER II – REVIEW OF THE LITERATURE

BACKGROUND
For most sports, it is difficult to achieve the desired success without a significant
amount of strength to assist with the athletic demands in a particular sport. Strength
training is one way to target both the neural and muscular components of muscular
adaptation, stressing the central nervous system while impacting the increase in muscle
mass. Methods used to target muscular adaptations include adjusting the intensity, scope
of work, duration, rest periods, and loads involved. The ideal program chooses the
methods that will produce the greatest effects in the shortest time period possible. Most
fitness professionals in today’s professional, collegiate, and recreationally competitive
society favor this approach.
RESISTANCE TRAINING
Due to the complexity of strength as a concept, it is necessary to break it down
into specific components. There are four basic methods of achieving maximal muscular
effort: lifting maximal resistance (the method of maximal effort), lifting submaximal
resistance to failure (repetitive effort) (Stankovic et al., 2013), lifting resistance as fast as
possible, termed dynamic effort; and lifting a submaximal load at a moderate volume of
repetitions for as the method of submaximal effort. In this investigation, we are
examining the lifting maximal resistance method to supplement the established research
(Richmond et al., 2014) on submaximal resistance to failure due to the acute effects of
inhalants to maximize their effect on the sympathetic nervous system. To test this
maximal method, this study tested subjects under a maximum load that they are able to
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lift only once in a slow, constant velocity (Baechle & Earle, 2008). The maximal
resistance method is considered as the most effective for improving intra- and intermuscular coordination and maximizing the effects of strength training. This method
requires the largest number of motor units with the best discharge frequency of the
nervous system (Stankovic et al., 2013). Although there is an inherent risk of injury due
to the load involved as well as increased conditions for muscle hypertrophy, this remains
the preferred method for measuring absolute strength for programming purposes. The
advantages of the maximal effort method in terms of muscle activation and adaptation
outweigh the disadvantages of having developed form, strength, and proper testing
progression at lower intensities; although this is without any supporting research
(Baechle & Earle, 2008; Ch. 12). The data obtained from the maximal effort method
allows the researcher to utilize mathematics to identify the intensities, loads, and
durations necessary to achieve the desired results in the athlete.
ENDOCRINE SYSTEM
Strength training has an effect on all of the body’s internal systems, including the
endocrine system, in particular the testosterone level.

During strength training,

testosterone is released to meet the demands placed on the body. This occurs in order to
control protein synthesis, muscular development, bone growth, and calcium retention
(Stankovic et al., 2013). Testosterone release as a result of resistance training is related to
the size of the exercising muscle mass, the total volume of training (defined as resistance
x repetitions x sets), and total duration of the training, with a higher emphasis being
placed on intensity as the main factor to alter catecholamine responses to exercise
(Zouhal et al., 2008). For the purpose of this thesis, testing will be geared toward the
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manipulation of the catecholamine response only, ignoring any other resulting effects or
stimulated chemical reactions in response to ammonia inhalation. However, due to the
lack of proper testing equipment and facilities, this study will be assuming that the
release of any hormones as a result of the ammonia inhalation is the HPA-axisfacilitating homeostasis maintenance (Silverman et al., 2005). The HPA axis has also
been observed as an avenue to respond to stress, which causes the release of metabolic
factors such as cortisol into the blood causing an increase in cardiac tissue glycogen
concentration levels (Embi & Scherlag, 2014). Although this study is not relating to the
phosphogen system focus of this study, it did demonstrate the effect of stress on
intramuscular substances affecting performance. In essence, the HPA axis responds to
psychological and physical stressors by utilizing the neuroendocrine feedback loop to
maintain or return to homeostasis (Handa & Weiser 2013). There seems to be no prior
research suggesting or identifying any effect on reflex up-regulation or motor
recruitment, suggesting that all targets and methods of influence are focused on hormonal
release or retention and receptor activity to achieve the desired influences on
performance.
PHYSIOLOGICAL EFFECT OF INHALANTS
Due to its highly irritating nature, ammonia inhalation causes rapid eye, nose, and
throat irritation, coughing, and possibly bronchospasms even at low concentrations.
However, due to its low odor threshold there is an early warning of its presence, and
olfactory adaptation and desensitization can occur and render it less detectable (Gorguner
& Akgun, 2010). When ammonia is inhaled, it forms ammonium hydroxide by reacting
with the water present in the mucus in the respiratory tract. This is the cause of
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immediate laryngospasm and laryngeal edema, while severe exposure can lead to noncardiogenic pulmonary edema, residual chronic lung disease in the forms of bronchitis,
bronchiectasis, airflow obstruction, interstitial fibrosis, and impaired gas exchange. These
acute effects are well known, and although there is less research on the long-term effects
of ammonia inhalation, it is thought that the extent of respiratory injury is dependent on
the duration of exposure, gas concentration, and depth of inhalation (Leduc et al., 1992).
This study included the preventative steps of utilizing small amounts of inhalants for a
brief, split-second inhalation. Subjects were exposed to brief ammonia inhalation a total
of six times throughout the study, and never within twenty-four hours of each instance,
minimizing both the duration and depth of the exposure. These brief exposures are
consistent with anecdotal observations of inhalant use by weight lifters in training and
competition.
Ammonia products are included in basic first aid kits in the forms of smelling
salts, ammonia capsules, and other products that are designed for preventing and treating
lightheadedness, fainting and dizziness (Velasquez, 2011). Ammonia products are also
being utilized for pre-lifting rituals before powerlifting attempts, “clearing an athlete’s
head” in sporting events such as football and boxing, and overall “psyching up” of the
individual. When inhaled, the ammonia instantaneously irritates the lungs, nose, and
mucous membranes of the nasal cavity (Gorguner & Akgun, 2010). This irritation leads
to an involuntary inhalation reflex while stimulating the respiratory muscles to a higher
work rate, which is thought to achieve a higher degree of consciousness and is one focus
of this study. Although ammonia is considered to be a toxic substance, its inhalation is
merely a symptom of relief since the dosages required to cause damage are at levels
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much greater than possible to achieve with over-the-counter products. There is an
inherent risk for individuals with certain underlying complications, such as asthma,
anaphylaxis, sickle cell traits, and other respiratory disorders. These potential
complications emphasize the importance of knowing the athlete and taking the proper
precautions with any respiratory issues, which may include rare usage, smaller dosages,
or avoidance all together. In spite of these potential complications, all of these ammonia
products are considered safe since they have met the requirements to be allowed in the
inventory of a standard medical kit, which is much less than the amounts considered
hazardous except in the absence of any underlying respiratory issues. However, in the
interest of safety and liability, screening of subjects for these exclusionary criteria was
conducted in this study despite the precaution of utilizing products considered safe for all
circumstances.
Past studies have utilized inhalants other than ammonia for the purpose of
manipulating the muscular and endocrine systems for performance enhancement. Decorte
et al., 2013, specifically observed the effects of salbutamol on neuromuscular function
during a quadriceps fatigue test, observing that inhaled β2-agonists increased quadriceps
endurance without any significant effect on neuromuscular activity in the form of
maximum voluntary contraction readings. Prior to this study, Decorte et al., (2008)
focused on both quadriceps fatigability and force output with the acute effects of
salbutamol inhalation. They reported no effect on strength, fatigue, and recovery of the
quadriceps in subjects without asthma. Similar findings were reported by Kindermann in
2007 during a qualitative review of 19 studies, in which 17 showed null effects on
muscular strength and performance from inhaled β2 agonists, although there were some
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effects following oral administration. This is supported by another review (Pluim et al.,
2011), in which β2-agonists showed no significant effects on endurance, strength, or
sprint performance in healthy athletes. Based on these reviews, there is scant evidence for
an effect of inhaled β2 agonists on performance.
PREVIOUS RESEARCH ON THE EFFECTS OF AMMONIA INHALANTS ON
MUSCULAR STRENGTH
Richmond et al., (2014) examined the effect of ammonia inhalants on bench press
and squat strength exercises in twenty-five male subjects. Subjects performed a
submaximal-load (85% of their 1-RM) maximal-repetition test. They found no difference
in repetition performance between the inhalant and placebo trials.

The researchers

attributed this to a possible need of a higher percentage of 1-RM. This change would
better utilize the anaerobic energy system that ammonia inhalation is hypothesized to
stimulate, and stay within the ideal time frame to utilize the effect of the ammonia, a time
period in which this study may have exceeded.
PREVIOUS RESEARCH ON INHALANTS AND EFFECTS ON
PERFORMANCE
In related studies, it has also been found that high-dose inhalations of salbutamol
have no effect on aerobic capacity or oxygen uptake (Elers et al., 2012). However, this
study also examined short-term performance of about 20-25 minutes of activity, where
the immediate effect of inhalants and the induced responses as a result take full effect
then decline within seconds of inhalation. Other studies have shown that inhalants could
have an effect on performance even with this small window of effect if administered at
the right time. For example, inhaling a therapeutic amount of salbutamol at the end of a
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cycling race increased sprint cycling performance at the end of the race (Bedi et al.,
1988). It has also been observed that usage of salbutamol (ß2-adrenergic agonist)
inhalants do not have an ergogenic effect on performance during a 5 km race (Dickinson
et al., 2014), where runners inhaled up to 1600 μg of salbutamol 15 minutes prior to
racing. Their goal was to stimulate bronchodilation to reduce airway resistance with the
result of increased oxygen minute ventilation and improved performance. Despite
differences in energy systems, the goal of this study was similar to that of Dickinson et
al., in 2014. Although this study was targeting a different inhalation response and energy
system, the objective was similar to that of Dickinson’s study: stimulation of a beneficial
response to inhalation of an involved system in the particular sport for a rapid and acute
increase in athletic performance with little or no side effects or traces. However, unlike
salbutamol, ammonia is not on the WADA prohibited substances list or even considered
at this point to be a candidate to be added to that list, making it not only a potential
ergogenic aid but also a legal one.
CONCLUSION
Research has shown ergogenic aids influence athletic performance through forced
adaptations and overloading of existing bodily systems. Some ergogenic aids result in
negative acute and chronic consequences. These consequences are the core reason why
many of these substances are banned by the WADA, as well as the unfair advantage
caused by their usage to increase existing bodily reactions and systems involved in
desirable outcomes. However, these substances are only supplements to a training
regimen, which is still the core of athletic performance.
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According to Bedi, et al. (1988), substances that do not have any adaptation
effects on natural occurring responses can be utilized to affect performance by dictating
when these responses, such as catecholamine release, occur. Without any chronic
adaptations, it has been observed that we can acutely influence the timing of beneficial
reactions without tampering with the systems already naturally structured in the body.
However, all of these tests have been conducted during moderate to long duration
exercise, eliminating any true effects on performance due to the short duration of effect
of the inhalants.
The goal of this study was to examine the short-term consequences of ammonia
inhalation on deadlift 1-repetition maximum. Focusing on the deadlift, a short duration
power exercise, eliminated the limitation of diminishing effects of ammonia inhalation on
a task of longer duration. Taking advantage of the body’s natural fight-or-flight reactions
and controlling the timing of their onset, the goal was to increase performance to the
same degree as the current banned techniques, while staying within the restrictions of the
WADA.
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CHAPTER III – METHODS
SUBJECTS
Subjects were college aged male and female undergraduate students
approximately 18-24 years of age. Subjects were recruited from the Exercise Science
undergraduate program at Old Dominion University, specifically from the EXSC 250,
Strength and Conditioning Leadership, in which they received extra credit points toward
their lecture grade in that course with the instructor’s approval. If students showed
interest in the study but did not meet the inclusionary criteria, they were allowed to
submit a resistance training specific article report for the same credit points, which was
made available for all students regardless of their interest in the study. All subjects were
required to have a minimum of two years of resistance training experience, specifically
experience with the deadlift exercise. Participants with a history of asthma,
lightheadedness, fainting, anaphylaxis, sickle cell traits, and other respiratory disorders
were excluded from the study due to the risk of fainting, rapid and involuntary
contraction of the neck and head for ammonia inhalation, and in significantly higher
doses not available in over-the-counter products, toxicity, sickness, and death. A total of
20 participants (10 females and 10 males) were recruited for the study. This study
included the preventative steps of utilizing small amounts of inhalants two inches from
the nose for a brief, split second inhalation. Subjects were only exposed a total of six
times throughout the study, and never within twenty-four hours of each instance,
minimizing both the duration and depth of the exposure.

Prior to all testing, the

Institutional Review Board of Old Dominion University approved the study protocol.
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Participants received a verbal explanation of the study and provided written informed
consent.
DESIGN
All subjects participated in a 1-RM test for the deadlift, with the subject
progressively performing single repetitions in increasing heavier loads until they
achieved one maximal effort that could not be surpassed by another effort. Equipment
utilized in the study included a standard Rogue Fitness (Columbus, Ohio) Echo Series
Bumper Plates (2.5, 5, 10, 15, 25, 35, 45, 55 pound options) and a standard 20-kg Rouge
28MM Training Bar. Testing took place on a standard Olympic regulation weightlifting
platform located in the Student Recreation Center (Pro-Maxima FW-147 8’ x 8’
platform). Subjects were allowed to use any weightlifting accessories such as Olympic
weightlifting shoes, belts, sleeves, etc., and were required to use the same equipment and
the same grip and lifting technique for all trials. The ammonia inhalant utilized in this
study was Pac-Kit (South Norwalk, CT) Ammonia Inhalants medical kit refills (2.125" x
4" x 0.625"), with the control substance being water in an identical bottle. Subjects
should have been able to use their experience with the deadlift to achieve maximal effort
within three to five repetitions of their initial warm-up, utilizing previous 1-RM tests as a
guide to the load selection for their attempts. The loads selected for these attempts as well
as the success and failure were recorded for testing design purposes during the trials later
in the study. Subjects had a minimum of 72 hours between each session to allow for full
recovery from their exertions and exposure to the particular inhalant in that trial.
Subjects followed the procedures in Tables 1 and 2 for the initial baseline 1-RM
test and both experimental trials, which were the experimental condition with the

17
ammonia supplementation or the control condition with water as the control substance.
Subjects were paired within sex by similar 1-RM baseline results and randomly assigned
to counterbalanced treatment orders. All substances involved in this study were stored in
blank bottles by a fellow graduate student for the blinding of both the researcher and the
research subjects. Using the data collected from the baseline maximal test, the researcher
calculated the progressive increase in weight (in percent) per each attempt for the subject
for both trials. Based on this information, subjects performed two repetitions at 65% and
two at 75% 1-RM, and one repetition at 85%, 90%, and 95% of 1-RM, followed by the
final attempt at either 100% and/or 100% and higher as stated in the following protocol.

Table 1. Standardized warm-up for each trial
1. 2 x 10 Fire Hydrants per leg
2. 2 x 10 second Lunge Stretches
3. 2 x 10 Dumbbell Good Mornings @ 10 & 20 pounds
4. 1 x 10 @ Barbell
5. 3 x 5 @ 45%
6. 2 x 3 @ 50%

For trial 1, the subject inhaled the assigned inhalant and attempted to lift 100% 1RM plus 2.5% of the 1-RM achieved in baseline testing. In trial 2 the subject inhaled the
same inhalant and attempted to lift 100% 1-RM plus 2.5, 5, and 7.5% respectively. In
these two trials, the subject was asked to set their feet and all other personal necessities
prior to the lift (tighten belt, set straps, etc.), take in one maximal inhalation from either
bottle one or two and perform the lift within 15 seconds of inhalation as the effects of the
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inhalant are felt. Trials were then repeated for the second inhalant with an identical
process to Trial 1 and Trial 2 in Trial 3. If the subject failed an attempt, they were
allowed a second attempt at the weight with identical procedures, including another
inhalation of the prescribed inhalant. All subjects had a timed rest interval of three
minutes between all attempts during this study for ideal recovery time without
compromising performance (Matuszak et al., 2003).

Table 2. TRIAL WEIGHT PROGRESSION BASED ON BASELINE 1-RM

Baseline
Ammonia
or Water

Warm-up
Methods
Table 1 p. 17
Methods
Table 1 p. 17

Remaining Methods
Trial
Table 1 p. 17

65%
x 2@

75%
x 2@

85%
x 1@

90%
x 1@

95%
x 1@

100%
x 1@

Trial
N/A*

x 2@

x 2@

x 1@

x 1@

x 1@

x 1@

x 2 @ x 2@

x 1@

x 1@

x 1@

x 1@

RM +
2.5, 5,
7.5%
RM +
2.5, 5,
7.5%

* Subject continues to perform single repetitions until a maximum lift was achieved that
could not be bettered.
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Table 3 TESTING DESIGN
Subject Recruitment

Baseline 1-RM Test

Matched Pairs for Counterbalance (Gender and Baseline)

72-Hour Minimum Recovery

1-RM Trial 2 (Water or Ammonia)

72 Hour Minimum Recovery

1-RM Trial 3 (Remaining Trial)

Counterbalanced Treatment Order (Trial Results)
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STATISTICAL ANALYSIS
Baseline descriptive variables (age, height, mass, years of weightlifting
experience) and 1-RM data for Trials 1, 2 and 3 were examined for normality. 1-RM
data were analyzed with repeated-measures analysis of variance with Bonferroni
adjustments for planned post-hoc comparisons using IBM SPSS (Version 21, Armonk,
NY). The criterion for statistical significance was be α=0.05. Unless otherwise indicated,
values were reported as mean±SD.
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CHAPTER IV – RESULTS

Ten male and 10 female subjects completed all three testing sessions. Baseline
characteristics are presented in Table 4. As expected, males were significantly heavier
and had greater (p≤0.05) absolute (kg) and relative (kg·kg-1) dead-lift performance. There
were no reported issues or injuries from participation in the study outside of normal
soreness and Delayed Onset of Muscle Soreness (DOMS) signs and symptoms. After
testing was completed for all subjects, the ammonia was revealed to be contained in
Bottle B, with Bottle A containing water for the controlled substance (Table 3). Matching
of subjects in pairs according to baseline performance and randomized assignment to
treatment order (water/ammonia; ammonia/water) resulted in no order effect (p=0.533).
Table 4. Baseline characteristics of subjects. Values are X ± SD.
________________________________________________________________________
Variable

Females (n=10)

Males (n=10)

Age (years)

22 ± 5

21 ± 1

Body mass (kg)*

66 ± 8

75.2 ± 6.8

Absolute Baseline dead-lift 1-RM (kg)*

93.0 ± 15.4

151.8 ± 42.3

Relative Baseline dead-lift 1-RM (kg·kg-1)* 1.42 ± 0.27

2.01 ± 0.5

________________________________________________________________________
*Males > Females, p≤0.05
The effect of treatments on absolute dead-lift performance is presented in Figure
1. As expected, there was a significant sex main effect (p<0.0001) in favor of males.
However, there was no trial main effect (p=0.874) or sex by trial interaction effect
(p=0.559).
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Figure 1. Subject Absolute Deadlift comparison between trials. Values are X±SE.
Female

Male

Absolute Deat-lift 1-RM (kg)

175.0

150.0

125.0

100.0

75.0

50.0
Baseline

Water
Trial

Ammonia

The effect of treatments on relative dead-lift performance is presented in Figure 2
with all relative calculations based on body mass measured at baseline. Males had greater
relative dead-lift strength across all trials compared to females (p<0.001), but there was
no trial main effect (p=0.946) or sex by trial interaction effect (p=0.553). This indicated
no difference across the trials within subjects, while confirming the absence of sex
interactions.
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Figure 2. Subject Relative Deadlift comparison between trials. Values are X±SE.

Relative Deat-lift 1-RM (kg·kg-1)

Female

Male

2.25

2.00

1.75

1.50

1.25

1.00
Baseline

Water
Trial

Ammonia

As shown in Figure 3, percent changes in absolute dead-lift strength (water vs.
baseline; ammonia vs. baseline; ammonia vs. water) were similar (p=0.869) with no
gender main effect (p=0.552) or gender by percent comparison interaction effect
(p=0.412)
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Figure 3. Percent changes in Absolute Deadlift strength. Values are X±SE.

Relative Deat-lift 1-RM (kg·kg-1)

Female

Male

5.00
4.00
3.00
2.00
1.00
0.00
-1.00
-2.00
-3.00
Percent change Water
vs. Baseline

Percent change
Ammonia vs.
Baseline

Percent change
Ammonia vs. Water
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CHAPTER V – DISCUSSION

Ammonia inhalants are often used during Olympic weightlifting and powerlifting
events for the purpose of improving athletic performance in both competitive and training
situations. However, this study has shown no significant difference in achieved 1-RM
loads between maximal deadlift attempts with ammonia compared to water or baseline
treatments in male and female recreational weightlifters. Although our data suggest there
is no effect on performance, more research is needed on this topic with emphasis on
ammonia concentration, greater recovery time allowed between trials, and standardizing
the time between trials.
Subjects commented during ammonia experimental trials that the inhalant made
them “more alert,” “more awake,” or “hyper-alert,” with confirming dilated eyes and
increased respiratory rate as observed by the researcher during testing. There was some
coughing as a result of the inhalant, although subjects exhibiting this response recovered
within seconds of its onset. The order of trials did not have a significant effect on testing.
One variable that this study failed to account for was the effect of final exams on the
subjects involved in the research. All subjects were students finishing the spring semester
of the 2015 school year; hence many subjects were not in their ideal or regular schedules
and habits. Issues such as sleep deprivation, altered diet inactivity, scheduling, sickness
(one subject, which more than likely was stress-induced from final exams between trials
and did not mention the illness until after testing), and stress may have impacted the
subjects’ performances. Training experience was another complication with the subjects.
Although many of the subjects had the required weightlifting experience, some subjects
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of both sexes had never tested their 1-RM for the deadlift, stating that their training goals
never required knowledge of their maximal effort abilities, which may account for the
slightly lower baseline achieved loads compared to the experimental trials in some
subjects, and hints at their ability to achieve greater loads due to just never having been
subjected to such a load. However, the absence of significant differences in deadlift 1RM between baseline and water or ammonia experimental conditions supports the
absence of a learning effect as well as the hypothesized treatment effect. With a subject
pool of this background, submaximal testing may have been more ideal due to its design
being more applicable to their training methods, but the focus of this study was
measurement of maximal strength. The short-term efficacy of ammonia in improving
deadlift 1-RM might be more apparent in more homogeneously experienced male and
female powerlifters. One recommendation for future study is the replication of this design
with such a study population against the utilized population of recreational lifters utilized
in this study.
Other uncontrolled variables in this study were the difference in techniques and
equipment utilized. These were standardized within subjects but not across the subject
pool in an effort to keep subjects in their ideal comfort state, as well as maintaining the
methods they use to train while not introducing new variables to a familiar task.
Approximately 33 percent of subjects used belts, which could have a significant effect on
their performance due to the increase ability to create and hold pressure in the torso,
allowing the maintenance of posture that would otherwise be compromised. One female
subject also utilized powerlifting straps, which eliminated her grip from the lift, which is
thought to be a major limiter of barbell movements (Ratamess et al., 2007). Overall,
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many different stances, grips, grip widths, and shoes were utilized by the subjects, all of
which individually could have significant effects on the subject’s performance. These
variations were expected due to different training goals, body mechanics, individual
weaknesses and strengths, all which are included in the process of identifying the method
used to perform the deadlift within the standard of reaching full torso, hip, and knee
extension while lifting the barbell from the floor. However, there was no protocol to
address any benefit of equipment or usage of different techniques within each subject and
the overall subject population since that was not the focus of this study.
For female subjects specifically, there was no tracking of the menstrual cycle,
which also could have had an effect on performance if testing was performed during
specific time frames of the cycle (Birch and Reilly, 2002), although overall there seems
to be no observed effect based on this study’s findings. One female subject lifted 205
pounds in her baseline trial, but only 185 pounds in the water trial, and then 155 pounds
in the ammonia trial. This could have been due to inability to recover from prior trials,
but the subject was shocked at her inability to reach her baseline value, which leaves the
cause for her performance up for question.
The concentration of the ammonia component could have also been a factor. In
many competitions, inhalants utilized can be up to three times the concentration of the
capsules utilized in this study. These concentrations were not tested due to subject safety,
with the focus being on the consistent amounts of fresh ammonia present in each capsule,
where competition smelling salts come in “bulk” bottles and have to be resealed after
each use. This study was also based on the assumption that ammonia is the substance
utilized during competitions.
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Timing could also have been a confounding variable within the study in a few
instances. Although each subject tested at the same time of day during the study, this was
determined by availability, not by individual ideal training time. A given subject might
have been in a more ideal training state in the afternoons, but was instead scheduled to
test in the mornings. The timing of the maximal lift could have been an issue. Some
subjects took longer to recover from the initial “hit” of the ammonia to the point where
after the lift (which was within 20 seconds of inhalation) subjects were still recovering
from the initial response to the ammonia. Future studies should standardize the time
between lifts and inhalation, not seconds so that subjects can be in the desired heightened
state, but have adequate time to begin returning to homeostasis. Although the
standardized recovery time between trials was enforced, for some subjects there was an
unexplained inability to fully return to homeostasis. There may be value in future studies
to keep subjects within twenty seconds between inhalation and lifting, while testing
different specific times within that range.
A major limitation in this study was the bottles containing water and ammonia
treatments. All substances were stored and administered in taped (for blinding) travel size
shampoo bottles, which were all discarded after use. To administer the substance after
shaking, the tester flipped open the cap of the bottle, where the subjects were inhaling the
substance through the narrow opening of the lid, which was much smaller than the
opening of the bottle itself. This taping of the capped bottle not only blinded the subject
but the researcher as well through all trials. Although this was planned for the purpose of
double-blinding, post-testing review reveals that the lids may have limited the subjects
from getting full exposure to the ammonia capsule. This could have prevented the
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subjects from getting the full exposure to the ammonia, as well as eliminated the need for
longer recovery time between inhalation and performing the lift. Future studies can also
benefit from a modified protocol utilizing more trials over a greater time period, with two
trials for both the water and ammonia treatments to provide more data on whether or not
there is an effect attributed to the ammonia, while limiting the possibility of the subject
being able to guess which substance is being utilized in that trial.
Reviewing the only prior research related to this topic, there was similar findings
by Richmond et al., in 2014 during submaximal testing of bench press and squat at 85%
of baseline maximal testing while inhaling Vick’s VapoRub. Similar to this study, there
was no observed differences between the experimental and blinding substances, while
still recommending athletes can continue to utilize the substance without negative
consequences to take advantage of any psychological effects due to usage, but at their
own decision. Although this study focused on submaximal testing compared to maximal
testing in this study, both studies are comparable, making two studies not finding any
significant effects attributed to inhalants on performance.
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CONCLUSION
In conclusion, this study is the first to truly test the effects of ammonia inhalation
on 1-RM testing. The acknowledged design flaws and limitations encountered in this
study underscore the importance of additional investigation. Future research should
examine the effect of ammonia inhalation in a more experienced study group with better
control over diurnal variations in strength measurement; potential effects of menstrual
cycle phases in female subjects; use of standardized equipment and technique; and lifts in
addition to the dead-lift. Within the limits of this study, there was no ergogenic effect of
ammonia inhalation on dead-lift performance in recreational male and female
weightlifters. Based on these findings, it is not recommended to strength and conditioning
professionals to incorporate inhalants into their training programs. Given these findings,
if athletes and/or coaches feel that ammonia inhalants have a psychological benefit for
their programs, there is no basis to encourage or discourage their usage if their athlete has
no prior medical issues or history similar to that which was screening in this study.
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Appendix 1- Subject Data
Subject

Age

Weight

Baseline

Trial A

Trial B

F1

20

148

230

245

235

F2

19

139

270

245

275

F3

22

131

215

225

215

F4

19

159

195

195

195

F5

34

176

210

215

220

F6

21

122

205

185

155

F7

21

131

155

170

165

F8

20

155

215

195

195

F9

25

165

195

210

210

F10

20

130

155

170

170

M1

22

177

290

290

295

M2

20

170

415

415

415

M3

21

139

230

240

250

M4

21

169.5

235

245

250

M5

22

189

425

425

425

M6

22

176

440

440

450

M7

21

155.5

205

225

230

M8

21

172.5

385

365

365

M9

19

151

290

290

290

M10

23

155

425

385

405
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Study Flyer
EXSC 250, 240 Extra Credit Opportunity

Subjects are needed for the following research study; participating will satisfy the current
extra credit requirements stated in your course syllabus. Alternate opportunities are
available if you do not met the requirements of participation in this study.

The Effects of Pre - Maximal Exertion Inhalation of Gaseous Agents and the
Performance Effects During Barbell Movements.

It has been observed at Olympic weightlifting meets with multiple athletes
inhaling fumes from ether a small bottle with an unknown substance, as well as actual
ammonia capsules prior to stepping on the platform for their lifts. This usage, while
obvious, has not been addressed or regulated due to ammonia (azane) not being in the
World Anti-Doping Agencies list of prohibited substances. This may be due to lack on
knowledge on its effects on performance, or because its effects are not severe/extreme
enough to warrant being included in the prohibited list. In this study, ammonia inhalant
capsules acquired from Pac-Kit First Aid safety Equipment Company will be utilized to
address the stimulant that we assume is what has been seen utilized in competition.

All subjects will undergo a 1-RM test for the deadlift, with the subject
progressively performing single repetitions in increasing heavier loads until they have
performed one maximal effort that cannot be surpassed by another effort. Equipment
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utilized in this study will be standard Rogue Fitness (Columbus, Ohio) Echo Series
Bumper Plates (2.5, 5, 10, 15, 25, 35, 45, 55 pound options) which will be utilized with a
standard 20-kg Rouge 28MM Training Bar, testing will take place on a standard Olympic
regulation weightlifting platform. Any weightlifting accessories will be allowed such as
Olympic weightlifting shoes, belts, sleeves, etc. Subjects must wear the same equipment
for all trials, while also performing or utilizing the same grip and lifting technique for all
trials. The ammonia inhalant being utilized in this study is Pac-Kit (South Norwalk, CT)
Ammonia Inhalants medical kit refills (2.125" x 4" x 0.625"), with the control substance
being water in an identical bottle. Subjects should use their experience with the deadlift
to achieve maximal effort within three to five repetitions of their initial warm-up,
utilizing previous 1-RM tests as a guide to the load selection for their attempts. The loads
selected for these attempts as well as the success and failure will be recorded for testing
design purposes during the trials later in the study. Subjects will have a minimum of 72hours between each session to allow for full recovery from their exertions and exposure
to the particular inhalant in that trial.
Subjects will follow the procedures in Table 1 for both the initial baseline 1-RM
test as well as for the experimental trials, after being counter-balanced to either the
experimental condition with the ammonia supplementation or the control condition with
water as the control substance. Subjects with similar 1-RM baseline results and gender
will be paired together for data analysis before the two experimental trials. All substances
involved in this study will have been stored in blank bottles by a mentoring faculty
member for the blinding of both the researcher and the research subjects. Using the data
collected from the baseline maximal test, the researcher will calculate the progressive
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increase in weight (in percent) per each attempt for the subject for both trials. Based on
this information, subjects will perform two repetitions at 65% and 75% 1-RM, and one
repetition at 85%, 90%, and 95%, of 1-RM, followed by the final attempt at either 100%
or 100% and higher.
For trial 1, the subject will be inhaling the assigned inhalant and attempting to lift
100% 1-RM plus 2.5% of the 1-RM achieved in baseline testing. In trial 2 the subject
will be inhaling the same inhalant and attempting to lift 100% 1-RM plus 5%. In these
two trials, the subject will be asked to set their feet and all other personal necessities prior
to the lift, take in one maximal inhalation from either bottle one or two and perform the
lift within 15 seconds of inhalation as the effects of the inhalant are felt. Trials will then
be repeated for the second inhalant with an identical process to Trial 1 and Trial 2 in Trial
3. If subject fails an attempt, they will be allowed a second attempt at the weight with
identical procedures, including another inhalation of the prescribed inhalant. All subjects
will have a timed rest interval of three minutes between all attempts during this study for
ideal recovery time without compromising performance (Matuszak et al. 2003).

Warm-up for Each Trial
1. 2 x 10 Fire Hydrants per leg
2. 2 x 10 second Lunge Stretches
3. 2 x 10 Dumbbell Good Mornings @ 10 & 20 pounds
4. 1 x 10 @ Barbell
5. 3 x 5 @ 45%
6. 2 x 3 @ 50%
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Table 1

Warm-

65%

75%

85%

90%

95%

100%

Trial

up
Trial 1

Methods

x 2@

x 2@

x 1@

x 1@

x 1@

x 1@

N/A

Trial 2

Methods

x 2@

x 2@

x 1@

x 1@

x 1@

x 1@

RM

+

2.5%
Trial 3

Methods

x2@

x 2@

x 1@

x 1@

x 1@

x 1@

RM

+

5%

*** By utilizing the subject’s bodyweight in the following formula, it will provide
another method of analyzing any improvement in strength due to the acute effects of the
prescribed inhalant.
Performance= Load Lifted / Bodyweight. Example- 445# / 190# bodyweight=2.34 score
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APPENDIX D
INFORMED CONSENT DOCUMENT
OLD DOMINION UNIVERSITY
PROJECT TITLE: The Effects of Pre - Maximal Exertion Inhalation of Ammonia
Agents and the Performance Effects During Deadlift Maximal Testing.

INTRODUCTION
The purpose of this form are to give you information that may affect your
decision whether to say YES or NO to participation in this research, and to record the
consent of those who say YES. The Effects of Pre - Maximal Exertion Inhalation of
Gaseous Agents and the Performance Effects During Barbell Movements. For the
purpose of this study, the methodology is designed to observe the possibility of
enhancing 1-RM (1 repetition for maximal load) lifts without the chronic consequences
commonly associated with established methods of performance enhancement,
specifically steroids and other such substances. The largest consideration is whether it is
possible to influence the body’s natural endocrine systems and processes without any
chronic side effects or consequences while staying within the current regulations in place
by the WADA. Specifically, we are trying to determine the possibility to being able to
utilize the acute consequences of inhaling small amounts of ammonia prior to
performance of a power exercise; in this case the deadlift exercise and the loads achieved
in a standard 1-RM test.
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RESEARCHERS
Principal Investigator
J. David Branch, B.A., M.S., Ph. D., Darden College of Education, HMS Associate
Professor; Responsible Project Investigator

Investigators
Justin Vigil, B.S., Darden College of Education, HMS Masters Student.
Phil Sabatini, B.S., M.S., HMS Lecturer
DESCRIPTION OF RESEARCH STUDY
The purpose of this study is to provide evidence for the ergogenic effect an
ammonia inhalant, a legal external substance, in increasing acute muscular strength as
measured by a deadlift 1-RM. This study is designed to assess the effect of ammonia
inhalant on the subject group with that of a control group between an ammonia inhalant
product and a water as a control substance.
If you decide to participate, then you will join a study involving research of
subjects will perform a 1-RM test for the deadlift, with you progressively performing
single repetitions in increasing heavier loads until you have performed one maximal
effort that cannot be surpassed by another effort. All subjects will undergo a 1-RM test
for the deadlift, with the subject progressively performing single repetitions in increasing
heavier loads until they have performed one maximal effort that cannot be surpassed by
another effort. Equipment utilized in this study will be standard Rogue Fitness
(Columbus, Ohio) Echo Series Bumper Plates (2.5, 5, 10, 15, 25, 35, 45, 55 pound
options) which will be utilized with a standard 20-kg Rouge 28MM Training Bar, testing
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will take place on a standard Olympic regulation weightlifting platform. Any
weightlifting accessories will be allowed such as Olympic weightlifting shoes, belts,
sleeves, etc. Subjects must wear the same equipment for all trials, while also performing
or utilizing the same grip and lifting technique for all trials The ammonia inhalant being
utilized in this study is Pac-Kit (South Norwalk, CT) Ammonia Inhalants medical kit
refills (2.125" x 4" x 0.625"), with the control substance being water in an identical
bottle. Subjects should use their experience with the deadlift to achieve maximal effort
within three to five repetitions of their initial warm-up, utilizing previous 1-RM tests as a
guide to the load selection for their attempts. The loads selected for these attempts as well
as the success and failure will be recorded for testing design purposes during the trials
later in the study. Subjects will have a minimum of 72-hours between each session to
allow for full recovery from their exertions and exposure to the particular inhalant in that
trial.
Subjects will follow the procedures in Table 1 for both the initial baseline 1-RM
test as well as for the experimental trials, after being counter-balanced to either the
experimental condition with the ammonia supplementation or the control condition with
water as the control substance. Subjects with similar 1-RM baseline results and gender
will be paired together for data analysis before the two experimental trials. All substances
involved in this study will have been stored in blank bottles by a mentoring faculty for
the blinding of both the researcher and the research subjects. Using the data collected
from the baseline maximal test, the researcher will calculate the progressive increase in
weight (in percent) per each attempt for the subject for both trials. Based on this
information, subjects will perform two repetitions at 65% and 75% 1-RM, and one

43
repetition at 85%, 90%, and 95%, of 1-RM, followed by the final attempt at either 100%
or 100% and higher.
For trial 1, the subject will be inhaling the assigned inhalant and attempting to lift
100% 1-RM plus 2.5% of the 1-RM achieved in baseline testing. In trial 2 the subject
will be inhaling the same inhalant and attempting to lift 100% 1-RM plus 5%. In these
two trials, the subject will be asked to set their feet and all other personal necessities prior
to the lift, take in one maximal inhalation from either bottle one or two and perform the
lift within 15 seconds of inhalation as the effects of the inhalant are felt. Trials will then
be repeated for the second inhalant with an identical process to Trial 1 and Trial 2 in Trial
3. If subject fails an attempt, they will be allowed a second attempt at the weight with
identical procedures, including another inhalation of the prescribed inhalant. All subjects
will have a timed rest interval of three minutes between all attempts during this study for
ideal recovery time without compromising performance.
Warm-up for Each Trial
1. 2 x 10 Fire Hydrants per leg
2. 2 x 10 second Lunge Stretches
3. 2 x 10 Dumbbell Good Mornings @ 10 & 20 pounds
4. 1 x 10 @ Barbell
5. 3 x 5 @ 45%
6. 2 x 3 @ 50%
Table 1
Warmup

65%

75%

85%

90%

95%

100%

Trial
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Trial 1 Methods x 2@

x 2@

x 1@

x 1@

x 1@

x 1@

N/A

Trial 2 Methods x 2@

x 2@

x 1@

x 1@

x 1@

x 1@

RM

+

2.5%
Trial 3 Methods x 2 @

x 2@

x 1@

x 1@

x 1@

x 1@

RM

+

5%

*** By utilizing the subject’s bodyweight in the following formula, it will provide
another method of analyzing any improvement in strength due to the acute effects of the
prescribed inhalant.
Performance= Load Lifted / Bodyweight. Example- 445# / 190# bodyweight=2.34 score

If you say YES, then your participation will last for 3 one-hour sessions with a minimum
of 48 hours between sessions at the Old Dominion Student Recreation Center, room
1006C and more specifically, the deadlift platform located within the facility.
Approximately 19 other subjects will be participating in this study.
EXCLUSIONARY CRITERIA
All subjects are required to have a minimum of two years of resistance training
experience to participate in this study. Any subjects with a history of or exhibiting any
cardiovascular issues including but not limited to asthma, lightheadedness, fainting,
anaphylaxis, sickle cell traits, and other respiratory disorders will be kept from
participating in the study.
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RISKS AND BENEFITS
RISKS: If you decide to participate in this study, then you may face a risk of muscle
injury (sprains, ligament strains), spinal injuries (pinched nerves, herniated disks, etc.),
hiatal hernias (rupture or tear in the abdominal cavity), or other injuries pertaining to
muscular exhaustion and overexertion. There is also an inherited risk of fainting, rapid
and involuntary contraction of the neck and head; and in significantly higher doses (not
available in over-the-counter products, hence should not be an issue in this study)
toxicity, sickness, and death. Ammonia levels will also be kept to minimal levels, far
from the concentrated levels required to put subjects at risk for toxicity. And, as with any
research, there is some possibility that you may be subject to risks that have not yet been
identified. AED devices and center staff certified in first aid and CPR response will be on
site, as well as the primary investigators also holding CPR, First Aid, and AED certified.
BENEFITS: There are no direct benefits for participation in this study.
COSTS AND PAYMENTS
The researchers want your decision about participating in this study to be absolutely
voluntary. Yet they recognize that your participation may pose some cost to park to
attend the trials, which there will be no assistance with.
NEW INFORMATION
If the researchers find new information during this study that would reasonably change
your decision about participating, then they will give it to you.
CONFIDENTIALITY
The researchers will take steps to keep private information confidential, such as giving all
subjects a number to protect their identity, while storing all identifying paperwork in a
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locked office. The researcher will remove identifiers from the information, destroy tapes,
store information in a locked filing cabinet prior to its processing. The results of this
study may be used in reports, presentations, and publications; but the researcher will not
identify you. Of course, your records may be subpoenaed by court order or inspected by
government bodies with oversight authority.

WITHDRAWAL PRIVILEGE
It is OK for you to say NO. Even if you say YES now, you are free to say NO later, and
walk away or withdraw from the study -- at any time. Your decision will not affect your
relationship with Old Dominion University, or otherwise cause a loss of benefits to which
you might otherwise be entitled. The researchers reserve the right to withdraw your
participation in this study, at any time, if they observe potential problems with your
continued participation.
COMPENSATION FOR ILLNESS AND INJURY
If you say YES, then your consent in this document does not waive any of your legal
rights. However, in the event of harm or injury arising from this study, neither Old
Dominion University nor the researchers are able to give you any money, insurance
coverage, free medical care, or any other compensation for such injury. In the event that
you suffer injury as a result of participation in any research project, you may contact Dr.
David Branch at 757-683-4514, Dr. George Maihafer the current IRB chair at 757683-4520 at Old Dominion University, or the Old Dominion University Office of
Research at 757-683-3460 who will be glad to review the matter with you.
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VOLUNTARY CONSENT
By signing this form, you are saying several things. You are saying that you have read
this form or have had it read to you, that you are satisfied that you understand this form,
the research study, and its risks and benefits. The researchers should have answered any
questions you may have had about the research. If you have any questions later on, then
the researchers should be able to answer them:

Justin Vigil 505-366-1257
Dr. David Branch 757-683-4514
Phil Sabatini 757-683-4995

If at any time you feel pressured to participate, or if you have any questions about your
rights or this form, then you should call Dr. George Maihafer, the current IRB chair, at
757-683-4520, or the Old Dominion University Office of Research, at 757-683-3460.

And importantly, by signing below, you are telling the researcher YES, that you agree to
participate in this study. The researcher should give you a copy of this form for your
records.

Subject's Printed Name & Signature

Date
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INVESTIGATOR’S STATEMENT
I certify that I have explained to this subject the nature and purpose of this research,
including benefits, risks, costs, and any experimental procedures. I have described the
rights and protections afforded to human subjects and have done nothing to pressure,
coerce, or falsely entice this subject into participating. I am aware of my obligations
under state and federal laws, and promise compliance. I have answered the subject's
questions and have encouraged him/her to ask additional questions at any time during the
course of this study. I have witnessed the above signature(s) on this consent form.

Investigator's Printed Name & Signature

Date
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HMS Testing Sheet

Subject:

Age:

Gender:

Weight:

Warm-up for Each Trial
1. 2 x 10 Fire Hydrants per leg
2. 2 x 10 second Lunge Stretches
3. 2 x 10 Dumbbell Good Mornings @ 10 & 20 pounds
4. 1 x 10 @ Barbell
5. 3 x 5 @ 45%
6. 2 x 3 @ 50%
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Table 1

Warm-

65%

75%

85%

90%

95%

100%

Trial

up
Trial 1

Methods

x 2@

x 2@

x 1@

x 1@

x 1@

x 1@

N/A

Trial 2

Methods

x 2@

x 2@

x 1@

x 1@

x 1@

x 1@

RM

+

2.5%
Trial 3

Methods

x2@

x 2@

x 1@

x 1@

x 1@

x 1@

RM

+

5%

*** By utilizing the subject’s bodyweight in the following formula, it will provide
another method of analyzing any improvement in strength due to the acute effects of the
prescribed inhalant.
Performance= Load Lifted / Bodyweight. Example- 445# / 190# bodyweight=2.34 score
Achieved Trial 1 Weights:
Baseline 1-RM achieved:
65%

75%

85%

90%

95%

100%

102.5%

105%

107.5%

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Y/N

Trial 2
“A”
Success Y / N
Trial 3
“B”
Y/N
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EXERCISE TEST SCREENING QUESTIONNAIRE
Read the questions to potential subjects and interpret the responses. Do not have
the person fill out the questionnaire
on his/her own.
ID # __________________________ Sex _____ Age _____ Date _______________
I. Risk Factors
___ 1.
___ 2. ___ 3. ___ 4.
___ 5. ___ 6. ___ 7.
Do you have a family history of heart disease? [heart attack, bypass surgery, angioplasty
or sudden death prior to the age of 55 (father or brother) or 65 (mother or sister)] Have
you smoked cigarettes in the past 6 months? Do you know if your blood pressure is
typically 140/90 or more? Do you take blood pressure medication?
Do you know if your LDL cholesterol is more than 130, or if your HDL cholesterol is
less than 40? If you don’t know your LDL, do you know if you total cholesterol is more
than 200? Do you know if your fasting glucose is more than 100? What is your height
and weight? [determine if BMI is > 30]
Do you usually obtain at least 30 minutes of moderate intensity physically activity most
days of the week? [A “No” answer is a risk factor]
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II. Symptoms
___ 1. ___ 2. ___ 3. ___ 4. ___ 5. ___ 6. ___ 7. ___ 8.
Do you ever have pain or discomfort in your chest or surrounding areas? (i.e., ischemia)
Do you ever feel faint or dizzy? (Other than when sitting up rapidly) Do you find it
difficult to breathe when you are lying down or sleeping? Do your ankles ever become
swollen? (Other than after a long period of standing)
Do you ever have heart palpitations, or an unusual period of rapid heart rate? Do you
ever experience pain in your legs? (i.e., fragmented claudication) Has a physician ever
said you have a heart murmur? (If yes, has he/she said it is OK, and safe for you to
exercise?) Do you feel unusually fatigued or find it difficult to breathe with usual
activities?
III. Other
___ 1.
___ 2. ___ 3. ___ 4.
Do you have any of the following diseases? Heart disease, peripheral vascular disease,
cerebrovascular disease, chronic obstructive pulmonary disease (emphysema or chronic
bronchitis) asthma (chronic), interstitial lung disease, cystic fibrosis, diabetes mellitus,
thyroid disorder, renal disease, or liver disease (For women) Do you think you may be
pregnant? Are you taking any medications, such as blood pressure medication, that
would affect your heart rate? Do you have any problem that might make it difficult for
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you to do strenuous exercise?
Eligible for study if: Is between 18-35 years old, has no more than 1 risk factor from
section I, has none of the symptoms in section II, and answers “No” to all questions in
section III.
Note: For individuals who do not know their blood glucose or blood lipid values, the
ACSM assumes they have those risk factors if they are males over 44 years of age or
females over 54 years of age, and assumes they do not have those risk factors if they are
younger. Since all subjects in the current study will be 35 years old or less, if they do not
know their blood values they will be assumed to not have those risk factors.
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